Jubilant Ingrevia Ltd.

JUBLINGREA

₹802.5

0.09% (0.7)

Market Cap

₹12,730 Cr.

P/E

72.51

About

Jubilant Ingrevia Limited is a global provider of Life Science products and solutions for Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial sectors. Their innovative and cost-effective… Read more

Jubilant Ingrevia Limited is a global provider of Life Science products and solutions for Phar… Read more

Low

420

52W Range

High

885

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days

Price & Performance

Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
ROE

Roe has decreased vs 10 year trend
Share price

Share price has increased over last 10 years but more due to rerating
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Sales Growth

Unable to calculate due to limited data

Market Share

52 %

(as of Mar 21)

Source/Historic

Cetyl Pyridinium Chloride - Market Share

26 %

(as of Mar 21)

Source/Historic

Cyanopyridines - Market Share

30 %

(as of Mar 21)

Source/Historic

Ethyl Acetate - Market Share

70 %

(as of Mar 21)

Source/Historic

Indian Acetic Anhydride - Market Share

9 %

(as of Mar 21)

Source/Historic

Life Science Chemicals - Market Share

22 %

(as of Mar 21)

Source/Historic

Pyridine and Picolines - Global Market Share

10 %

(as of Mar 21)

Source/Historic

Specialty Alcohol - Market Share

13 %

(as of Mar 21)

Source/Historic

Specialty Chemicals - Market Share

20 %

(as of Sep 22)

Source/Historic

Vitamin B3 - Market Share

69 %

(as of Sep 22)

Source/Historic

Vitamin B4 - Market Share

Revenue mix

Segment Break-Up

Location Wise Break-Up - Life Science Chemicals

Location Wise Break-Up - Specialty Chemicals

Location Wise Break-Up - Nutrition & Health Products

Location Wise Break-Up

Verticals

Operating Profit Break-Up

Capex

Asset Break-Up - Segment Wise

Asset Break-Up

Operational Metrics

Capacity Utilization - Nutrition & Health Solutions (%)
Source
Capacity Utilization - Life Science Chemicals (%)
Source
Capacity Utilization - Speciality Chemicals (%)
Source
Manufacturing Capacity - Speciality Chemicals (MTPA)
Source

Peer Comparison

Suppliers

Punjab Chemicals & Crop Protection Ltd.
Hitech Corporation Ltd.

FAQs on Jubilant Ingrevia Ltd. Business

What does Jubilant Ingrevia do?

Jubilant Ingrevia Limited is a global provider of innovative solutions and products serving various industries such as pharmaceutical, nutrition, agrochemical, and consumer, with a focus on quality and customization.

Who are the competitors of Jubilant Ingrevia?

Jubilant Ingrevia major competitors are Fairchem Organics, Alivus Life Sciences, Aether Industries, Archean Chem Inds, Chemplast Sanmar, Laxmi Organic Inds., GHCL.
Market Cap of Jubilant Ingrevia is ₹12,730 Crs.
While the median market cap of its peers are ₹7,801 Crs.

Is Jubilant Ingrevia financially stable compared to its competitors?

Jubilant Ingrevia seems to be less financially stable compared to its competitors.
Altman Z score of Jubilant Ingrevia is 5.83 and is ranked 7 out of its 8 competitors.

View FAQ's On Shareprice

Monopoly Companies

Companies which are dominant in a product, usually having a strong moat.

Run Query

Superstar Favourites

Companies where superstar investors like Rakesh Jhunjhunwala, Asish Kacholia have invested

Run Query

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Dec	Sep		Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec